CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-08-14. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 2545 · Search date 2026-08-14 · Methodology v1.0

LUCAS mechanical chest compression,
does it really help with Increased survival and survival with favorable neurologic outcome versus standard manual compression?

30-Second Summary
D
Evidence Grade D · 34 · Safety caution
LUCAS mechanical compression did not improve survival over manual CPR in two large randomized trials.
Use requires training to avoid malposition, interruptions, chest injury, and delayed defibrillation. It should follow emergency-service protocols under a trained resuscitation team.
What the
research shows
The grade is D. In 2,589-participant LINC, four-hour survival was 307/1,300 (23.6%) versus 305/1,289 (23.7%), difference -0.05 points (95% CI -3.3 to 3.2). On the common roughly 30-day timescale, one-month survival was 112/1,300 (8.6%) versus 109/1,289 (8.5%), difference 0.16 points (95% CI -2.0 to 2.3), and favorable neurologic survival was 105/1,300 (8.1%) versus 94/1,289 (7.3%). In 4,471-participant PARAMEDIC, 30-day survival was 104/1,652 (6.3%) versus 193/2,819 (6.8%), adjusted OR 0.86 (95% CI 0.64 to 1.15). Two large trials repeatedly failed to support increased survival, but no prespecified clinical-benefit threshold allows exclusion of meaningful benefit, giving D with 34 points.
What the
ads claim
The device's ability to repeat compressions at set parameters is real, but that fact does not establish greater patient survival than standard manual CPR. Operational advantages in special transport or procedural settings require a separate claim.
*

Useful facts when choosing a product

  • LUCAS is a piston device that repeats programmed chest compressions and can replace continuous manual compression by rescuers.
  • LINC compared a mechanical-CPR algorithm that also included defibrillation during ongoing compressions.
  • In PARAMEDIC, 60% of the mechanical-assigned group received the device, versus less than 1% of controls.
ID

Chamgap Semantic Classification Code

Candidate index · review held

UNK.lucas-automated-mechanical-chest-compression.UNK.survival-and-survival-with-favorable-neurologic-outcome.increase.UNK

Unknown > LUCAS automated mechanical chest compression > Unknown > survival and survival with favorable neurologic outcome > Increase claim > Unknown

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 2545 · D 34
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Rubertsson's LINC individually randomized 2,589 participants and used the NCT00609778 four-hour survival outcome as primary. It was initiated by Uppsala University and sponsored by Physio-Control/Jolife. Perkins's PARAMEDIC cluster-randomized ambulance vehicles and analyzed 4,471 patients, using 30-day survival from ISRCTN08233942 as primary. Outcome collection was masked, but only 985/1,652 (60%) assigned to mechanical compression actually received LUCAS, an implementation limitation. PARAMEDIC was NIHR funded.

02

Why this is classified as D (34)

Independent large trials repeatedly failed to support increased survival in the same indication, but no prespecified clinical-benefit threshold and benefit-compatible intervals prevent a definitive F, giving D with 34 points.

Counterpoint. D does not mean the device has no operational role. It means superiority over manual CPR for survival has not been established.

Rejudgment record. Cross-check applied — We cross-checked primary and common longer-term survival, neurologic survival, confidence intervals, funding, randomization units, and actual device use against both articles and registries and confirmed the absence of a prespecified clinical-benefit threshold.

Stored scoring profile
EndpointHHard endpoint - actual events such as death
ReplicationRXRepeatedly refuted in the same indication
IndependenceI1Mixed funding sources
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

Stored derived and displayed grades match; this is not a current recalculation or validity check (D).

▦

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
LUCAS improves survival over manual CPR after out-of-hospital cardiac arrest.DTwo large trials found no benefit in four-hour, 30-day, or common longer-term survival outcomes.
LUCAS improves survival with favorable neurologic outcome over manual CPR after out-of-hospital cardiac arrest.DNeither LINC at one month nor PARAMEDIC at three months showed significant benefit.
✓

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Rubertsson S et al., LINC 2014Individually randomized trial across six emergency medical systems2,589 randomized and analyzed, 1,300 versus 1,289Uppsala University institutional grants and Physio-Control/Jolife AB sponsorshipPrimary four-hour survival; one- and six-month survival with favorable neurologic statusFour-hour survival 307/1,300 versus 305/1,289, difference -0.05 points (95% CI -3.3 to 3.2); one-month survival 112 versus 109, difference 0.16 (-2.0 to 2.3); one-month favorable neurologic survival 105 versus 94, difference 0.78 (-1.3 to 2.8)Large mixed-funded repeatedly null evidence
Perkins GD et al., PARAMEDIC 2015Pragmatic cluster-randomized trial at the ambulance-vehicle level4,471 in intention-to-treat analysis, 1,652 versus 2,819; 985 mechanical-assigned patients received the deviceNIHR Health Technology Assessment ProgrammeThirty-day survival and three-month survival with favorable neurologic outcomeThirty-day survival 104/1,652 versus 193/2,819, adjusted OR 0.86 (95% CI 0.64 to 1.15); favorable neurologic survival at three months 77/1,649 versus 168/2,815Large independent publicly funded repeatedly null evidence
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-14).

Rubertsson S, Lindgren E, Smekal D, et al. Mechanical Chest Compressions and Simultaneous Defibrillation vs Conventional Cardiopulmonary Resuscitation in Out-of-Hospital Cardiac Arrest: The LINC Randomized Trial. JAMA. 2014;311(1):53-61. PMID: 24240611. DOI: 10.1001/jama.2013.282538. NCT00609778.
checked
Perkins GD, Lall R, Quinn T, et al. Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised controlled trial. Lancet. 2015;385(9972):947-955. PMID: 25467566. DOI: 10.1016/S0140-6736(14)61886-9. ISRCTN08233942.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-08-14 · Corrections: none
↗

Cite this verdict

LUCAS mechanical chest compression x survival after out-of-hospital cardiac arrest Evidence Grade D card
[Chamgap] LUCAS mechanical chest compression x survival after out-of-hospital cardiac arrest — Evidence Grade D·34. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/lucas-mechanical-chest-compression-out-of-hospital-cardiac-arrest-survival/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.
↑